Zacks Investment Research
28 May 2026, 22:46 UTC · 20h ago
Source · https://www.zacks.com/stock/news/2928648/viking-therapeutics-inc-vktx-exceeds-market-returns-some-facts-to-consider?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2928648
Read source
Story key points
3 claims · impact-rated
Viking Therapeutics (VKTX) is projected to report a year-over-year earnings decline of 108.62% in its upcoming release. — A massive projected drop in earnings per share typically triggers negative investor sentiment leading up to and following the report.
-0.60The Zacks Consensus EPS estimate for Viking Therapeutics has shifted 23.57% downward over the past month. — Downward revisions by analysts suggest deteriorating fundamental expectations and typically lead to selling pressure.
-0.50Viking Therapeutics currently holds a Zacks Rank of #3 (Hold). — A hold rating indicates a neutral outlook, suggesting no immediate strong catalyst for price movement in either direction.
+0.00Ticker attribution
Model heads
Continue reading
6 related stories
Search tags
The company is projected to report a significant year-over-year decline in earnings and has seen consensus EPS estimates shift downward by 23.57% over the past month.
Ranked #2 in total page views over the last 7 trading days, indicating high investor interest.
Experienced the highest page view growth (453.33%) over the last 3 trading days.
Ranked #4 in total page views over the last 7 trading days, indicating high investor interest.
Experienced significant page view growth (177.39%) over the last 3 trading days.
Experienced significant page view growth (298.78%) over the last 3 trading days.
Ranked #3 in total page views and shows strong growth in page views over the last 3 trading days.
Experienced significant page view growth (261.88%) over the last 3 trading days.
Ranked #7 in total page views over the last 7 trading days, indicating high investor interest.
Experienced significant page view growth (229.52%) over the last 3 trading days.
Experienced significant page view growth (259.62%) over the last 3 trading days.
Ranked #1 in total page views over the last 7 trading days, indicating high investor interest.
No ticker relationship head found.
Impact vectors
1 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
Zacks Investment Research
1h ago
